A possible anticancer drug delivery system based on carbon nanotube–dendrimer hybrid nanomaterials

Abstract

Iron oxide nanoparticles, γ-Fe₂O₃NP, were deposited onto the surface of multi-walled carbon nanotubes and CNT/γ-Fe₂O₃NP hybrid nanomaterials were obtained. Then linear-dendritic ABA type block copolymers consisting of polyethylene glycol as B block and poly(citric acid) as A block, PCA–PEG–PCA, were synthesized and cisplatin (cis-diamminedichloroplatinum (CDDP)—a platinum-based chemotherapy drug) was conjugated with their carboxyl functional groups and CDDP/PCA–PEG–PCA anticancer prodrugs were prepared. Noncovalent interactions between CDDP/PCA–PEG–PCA anticancer prodrugs and CNT/γ-Fe₂O₃NP hybrid nanomaterials led to CDDP/PCA–PEG–PCA/CNT/γ-Fe₂O₃NP drug delivery systems. There are several key features of these hybrid drug delivery systems: (i) their ability to cross cell membranes and also high surface area per unit weight for high drug loading assigned to CNTs, (ii) high functionality, water solubility and biocompatibility assigned to PCA–PEG–PCA linear-dendritic copolymers and (iii) targeting tumors using a magnetic field assigned to γ-Fe₂O₃ nanoparticles. The efficacy of drug delivery systems for killing the cancer cells and targeting the drugs towards tumors was investigated.